Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07019090
What this trial is testing

Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Haisco Pharmaceutical Group Co., Ltd. 120
Not applicableStudy completedNCT05028894
What this trial is testing

23andMe IPF Research Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
23andMe, Inc. 690
Not applicableWithdrawnNCT03258801
What this trial is testing

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Dr. Christopher Lambers
Not applicableUnknownNCT02479126
What this trial is testing

Interstitial Lung Diseases in the Veterans Administration

Who this might be right for
Interstitial Lung Disease
Robert Tighe 3,000
Post-approval studies (Phase 4)Ended earlyNCT03717012
What this trial is testing

Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 19
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Not applicableActive Not RecruitingNCT07577115
What this trial is testing

Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)Exposure Occupational+10 more
Istituto Clinico Humanitas 1,000
Early research (Phase 1)Study completedNCT07036029
What this trial is testing

NAL ER IPF Respiratory Function and Safety Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics 9
Testing effectiveness (Phase 2)Looking for participantsNCT03500731
What this trial is testing

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Who this might be right for
Idiopathic Pulmonary FibrosisEmphysema or COPD
Paul Szabolcs 8
Testing effectiveness (Phase 2)Study completedNCT00262405
What this trial is testing

Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 44
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Not applicableStudy completedNCT02173145
What this trial is testing

Azithromycin in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisCough
Insel Gruppe AG, University Hospital Bern 27
Testing effectiveness (Phase 2)Study completedNCT04072315
What this trial is testing

Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 9
Testing effectiveness (Phase 2)WithdrawnNCT03591926
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Biosplice Therapeutics, Inc.
Not applicableUnknownNCT01809574
What this trial is testing

The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Disease
Meir Medical Center 60
Early research (Phase 1)UnknownNCT00129350
What this trial is testing

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

Who this might be right for
EmphysemaAlveolitis, FibrosingCystic Fibrosis+2 more
Royal Brompton & Harefield NHS Foundation Trust 60
Not applicableLooking for participantsNCT05098717
What this trial is testing

End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation

Who this might be right for
Idiopathic Pulmonary FibrosisMechanical Ventilation Pressure High
University of Modena and Reggio Emilia 40
Not applicableStudy completedNCT03979703
What this trial is testing

Yoga in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Fibrosing Interstitial Lung DiseasesIdiopathic Pulmonary Fibrosis
Heidelberg University 17
Not applicableUnknownNCT03171870
What this trial is testing

Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assiut University 1
Early research (Phase 1)Temporarily pausedNCT04643769
What this trial is testing

Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Orinove, Inc. 24
Next Page